UCB touts plan for 'major' US investment to boost biologics capacity
Belgium's UCB is adding its name to the mix of drugmakers planning to grow their manufacturing footprints in the U.S.
Belgium's UCB is adding its name to the mix of drugmakers planning to grow their manufacturing footprints in the U.S.
